Section one: Contracting authority/entity
one.1) Name and addresses
Wolverhampton City Council
Civic Centre, St Peters Square
Wolverhampton
WV1 1RL
Contact
Mr John Thompson
john.thompson@wolverhampton.gov.uk
Telephone
+44 1902554503
Country
United Kingdom
NUTS code
UKG39 - Wolverhampton
Internet address(es)
Main address
http://www.wolverhampton.gov.uk
Buyer's address
http://www.wolverhampton.gov.uk
one.4) Type of the contracting authority
Regional or local authority
one.5) Main activity
General public services
Section two: Object
two.1) Scope of the procurement
two.1.1) Title
CWC21178 - Vaccination Services
Reference number
DN579527
two.1.2) Main CPV code
- 85121200 - Medical specialist services
two.1.3) Type of contract
Services
two.1.4) Short description
The enhanced vaccination programme will consist of two elements:
• Mobile and roving clinical vaccination provision offered across the city to priority cohorts including eligible cohorts who remain unvaccinated, Middle Layer Super Output priority areas (MSOA), businesses, university students and homelessness and new arrival providers. The roving and mobile model will enable the administration of Covid-19 vaccines at flexible locations outside of existing vaccination site provision to residents of Wolverhampton. The aim of roving and mobile provision is to improve access and maximise vaccine uptake in certain geographical areas, communities or among groups with low coverage.
• An outreach and engagement programme consisting of a multipronged approach in order to drive uptake and will include the following themes: partnerships, access and communications. This will involve analysis and identification of the highest priority low uptake groups and further segmentation to understand the root causes of vaccine hesitancy and solutions to deliver successful interventions to drive uptake.
two.1.6) Information about lots
This contract is divided into lots: No
two.1.7) Total value of the procurement (excluding VAT)
Value excluding VAT: £250,000
two.2) Description
two.2.3) Place of performance
NUTS codes
- UKG39 - Wolverhampton
two.2.4) Description of the procurement
The enhanced vaccination programme will consist of two elements:
• Mobile and roving clinical vaccination provision offered across the city to priority cohorts including eligible cohorts who remain unvaccinated, Middle Layer Super Output priority areas (MSOA), businesses, university students and homelessness and new arrival providers. The roving and mobile model will enable the administration of Covid-19 vaccines at flexible locations outside of existing vaccination site provision to residents of Wolverhampton. The aim of roving and mobile provision is to improve access and maximise vaccine uptake in certain geographical areas, communities or among groups with low coverage.
• An outreach and engagement programme consisting of a multipronged approach in order to drive uptake and will include the following themes: partnerships, access and communications. This will involve analysis and identification of the highest priority low uptake groups and further segmentation to understand the root causes of vaccine hesitancy and solutions to deliver successful interventions to drive uptake.
two.2.11) Information about options
Options: No
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
Section four. Procedure
four.1) Description
four.1.1) Type of procedure
Negotiated without a prior call for competition
- The works, supplies or services can be provided only by a particular economic operator for the following reason:
- absence of competition for technical reasons
- Extreme urgency brought about by events unforeseeable for the contracting authority
Explanation:
Access to vaccines is only available via an NHSEI approved supplier therefore the provider market is extremely limited.
Vaccination Services covered under this programme offer an enhancement to existing vaccination provision and are intended to significantly reduce the size of the unvaccinated eligible population. The enhanced service is required as existing NHS vaccination provision is focused on emerging cohorts (ages 12-15) and booster vaccinations. Therefore, this provision will aim to reduce the levels of individuals who remain unvaccinated.
The contract will be awarded following a 10 day standstill period concluding at midday on 12/11/2021.
four.1.8) Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: No
Section five. Award of contract/concession
Contract No
CWC21178
A contract/lot is awarded: Yes
five.2) Award of contract/concession
five.2.1) Date of conclusion of the contract
26 October 2021
five.2.2) Information about tenders
The contract has been awarded to a group of economic operators: No
five.2.3) Name and address of the contractor/concessionaire
Central Healthcare Solutions Limited
3mc Middlemarch Business Park, Siskin Drive
Coventry
CV3 4FJ
Country
United Kingdom
NUTS code
- UKG39 - Wolverhampton
National registration number
10853992
The contractor/concessionaire is an SME
Yes
five.2.4) Information on value of contract/lot/concession (excluding VAT)
Total value of the contract/lot/concession: £250,000
Section six. Complementary information
six.4) Procedures for review
six.4.1) Review body
Tracey Christie
Wolverhampton
governance@wolverhampton.gov.uk
Country
United Kingdom